Theravance Biopharma
TBPH
TBPH
92 hedge funds and large institutions have $900M invested in Theravance Biopharma in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5.06% less ownership
Funds ownership: 86.61% → 81.55% (-5.1%)
6% less funds holding
Funds holding: 98 → 92 (-6)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Holders
92
Holding in Top 10
1
Calls
$1.83M
Puts
$789K
Top Buyers
| 1 | +$3.75M | |
| 2 | +$2.52M | |
| 3 | +$1.49M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.46M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.4M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$12M | |
| 3 | -$5.53M | |
| 4 |
JG
Jefferies Group
New York
|
-$5.02M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$4.33M |